M
Mazduti.de
Dual Receptor Agonist

Understanding Mazdutide

A comprehensive resource exploring the science, clinical research, and therapeutic potential of mazdutide—a novel GLP-1/glucagon receptor agonist.

Comprehensive Mazdutide Information

Explore the science behind this innovative dual receptor agonist

Mechanism of Action
Understanding how mazdutide activates GLP-1 and glucagon receptors to regulate metabolic function.
Clinical Research
Latest findings from clinical trials examining efficacy, safety, and therapeutic outcomes.
Metabolic Benefits
Exploring the impact on weight management, glucose control, and cardiometabolic risk factors.
Evidence-Based
Comprehensive analysis grounded in peer-reviewed research and clinical data.

What is Mazdutide?

Mazdutide (IBI362/LY3305677) is a dual receptor agonist that simultaneously targets GLP-1 (glucagon-like peptide-1) and glucagon receptors. This mechanism of action represents an innovative approach to metabolic health management.

By engaging multiple metabolic pathways, mazdutide has shown promise in clinical research for addressing obesity, type 2 diabetes, and related metabolic conditions. The compound's ability to modulate appetite, enhance insulin secretion, and promote energy expenditure makes it a subject of significant scientific interest.

In China, mazdutide is approved for chronic weight management and glycemic control in adults with type 2 diabetes; it remains investigational in other regions.

This website serves as a comprehensive resource for understanding mazdutide's pharmacology, clinical development, and potential therapeutic applications, all grounded in current scientific evidence.

Stay Informed About Mazdutide Research

Explore our comprehensive collection of articles covering clinical trials, mechanism of action, and therapeutic potential.